ESC 365 - Empagliflozin reduces the doxorubicine-induced myocardial dysfunction.

ESC Premium Access

Empagliflozin reduces the doxorubicine-induced myocardial dysfunction.

Session: Best Posters 5 - Best Posters in comorbidities in heart failure

Topic: Ventricular function / haemodynamics

Speaker: Doctor J. Sabatino (Padova, IT)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Jolanda Sabatino

University of Padua, Padova (Italy)

1 presentation

0 follower

4 more presentations in this session

Best Posters in comorbodities in heart failure

Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action

Speaker: Doctor P. Efentakis (Athens, GR)

Cardiorenohepatic syndrome reflects severity of decompensated heart failure and is related with worse prognosis

Speaker: Associate Professor A. Soloveva (Saint Petersburg, RU)

Iron deficiency predicted hospitalizations in elderly patients with symptoms of heart failure

Speaker: Mrs M. Olofsson (Skelleftea, SE)

Access the full session

Best Posters 5 - Best Posters in comorbidities in heart failure

Speakers: Doctor J. Sabatino, Doctor P. Efentakis, Associate Professor A. Soloveva, Mrs M. Olofsson

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources